Form 4 for RIGL RIGEL PHARMACEUTICALS INC
Accepted 2023-02-06 00:00:00 ET · period of report 2023-02-02 · accession 0001140361-23-004732 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-02-06 | 2023-02-02 | RIGL | Schorno Dean L | EVP, CFO | S - Sale | $1.66 | -5,389 | 196.5K | -3% | -$8,946 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-02 | S | D | 5,389 | $1.66 | 196,519 | D | — | — |